News & Updates

Among patients with type 2 diabetes mellitus and cardiovascular disease, those with concomitant chronic obstructive pulmonary disease (COPD) are at higher risk of mortality and adverse cardiorenal outcomes, including heart failure, according to post hoc analyses of the EMPA-REG OUTCOME trial. However, these outcomes can be prevented with empagliflozin treatment, regardless of the presence of COPD.

Trajectories of body roundness index (BRI) appear to predict the risk of cardiovascular disease (CVD), particularly among younger adults, suggests a study.

Use of tumour necrosis factor inhibitor (TNFi) does not appear to contribute to incident hypertension in individuals with ankylosing spondylitis (AS), reports a study.

Following an episode of myocardial infarction (MI), patients with light or moderate alcohol consumption appear to have a lower risk of mortality than nondrinkers, according to a study.

Global wall motion score index (WMSI), as well as abnormalities in any of the left ventricular (LV) regional walls, is associated with the risk of incident heart failure (HF), reports a new study.